Retinal Vasculitis and Intraocular Inflammation after Intravitreal Injection of Brolucizumab

Volume: 127, Issue: 10, Pages: 1345 - 1359
Published: Oct 1, 2020
Abstract
Purpose To evaluate features and outcomes of eyes with retinal vasculitis and intraocular inflammation (IOI) after intravitreal injection (IVI) of brolucizumab 6 mg/0.05 ml for treatment of neovascular age-related macular degeneration. Design Retrospective case series. Participants Fifteen eyes from 12 patients identified from 10 United States centers. Methods Review of patient demographics, ophthalmologic examination results, and retinal...
Paper Details
Title
Retinal Vasculitis and Intraocular Inflammation after Intravitreal Injection of Brolucizumab
Published Date
Oct 1, 2020
Volume
127
Issue
10
Pages
1345 - 1359
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.